Fukushima Radiation May Be Increasing Pediatric Thyroid Cancer Rates
the ONA take:
Children living near the Fukushima nuclear meltdowns in Japan have a much higher rate of thyroid cancer diagnoses than that of children elsewhere, a new study published online ahead of print this week in the journal Epidemiology has shown.
Of the 137,000 children living in the Fukushima prefecture that have undergone ultrasound checkups since the March 2011 Fukushima Dai-ichi nuclear plant meltdowns after a tsunami ravaged the area, 137 have suspected or confirmed thyroid cancer as of August 2015—an increase of 25 cases from 1 year prior.
Compared with children living elsewhere, thyroid cancer occurs in approximately one or two of every million children per year.
Other researchers believe the increased rates of thyroid cancer may be attributable to increased screening.
“Dr. Tsuda's study had limitations including assessment of individual radiation dose levels to the thyroid and the ability to fully assess the impact of screening on the excess cases detected,” Andrew F. Olshan, professor at the Department of Epidemiology at the University of North Carolina, in Chapel Hill said.
Children living near the Fukushima nuclear meltdowns in Japan have a much higher rate of thyroid cancer diagnoses than that of children elsewhere.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|